Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19819121rdf:typepubmed:Citationlld:pubmed
pubmed-article:19819121lifeskim:mentionsumls-concept:C0011860lld:lifeskim
pubmed-article:19819121lifeskim:mentionsumls-concept:C0920317lld:lifeskim
pubmed-article:19819121lifeskim:mentionsumls-concept:C1801960lld:lifeskim
pubmed-article:19819121lifeskim:mentionsumls-concept:C0009566lld:lifeskim
pubmed-article:19819121lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:19819121lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:19819121pubmed:issue9lld:pubmed
pubmed-article:19819121pubmed:dateCreated2009-10-27lld:pubmed
pubmed-article:19819121pubmed:abstractTextIn patients with type 2 diabetes mellitus, the relationship between lowering glycated hemoglobin (HbA(1c)) and macrovascular complications is not clear and therefore lowering the level of HbA(1c) is controversial.lld:pubmed
pubmed-article:19819121pubmed:languageenglld:pubmed
pubmed-article:19819121pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19819121pubmed:citationSubsetIMlld:pubmed
pubmed-article:19819121pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19819121pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19819121pubmed:statusMEDLINElld:pubmed
pubmed-article:19819121pubmed:monthNovlld:pubmed
pubmed-article:19819121pubmed:issn1590-3729lld:pubmed
pubmed-article:19819121pubmed:authorpubmed-author:NIEElld:pubmed
pubmed-article:19819121pubmed:authorpubmed-author:YangWWlld:pubmed
pubmed-article:19819121pubmed:authorpubmed-author:WehLLlld:pubmed
pubmed-article:19819121pubmed:authorpubmed-author:ZhuWWlld:pubmed
pubmed-article:19819121pubmed:authorpubmed-author:Falklld:pubmed
pubmed-article:19819121pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19819121pubmed:volume19lld:pubmed
pubmed-article:19819121pubmed:ownerNLMlld:pubmed
pubmed-article:19819121pubmed:authorsCompleteYlld:pubmed
pubmed-article:19819121pubmed:pagination596-603lld:pubmed
pubmed-article:19819121pubmed:meshHeadingpubmed-meshheading:19819121...lld:pubmed
pubmed-article:19819121pubmed:meshHeadingpubmed-meshheading:19819121...lld:pubmed
pubmed-article:19819121pubmed:meshHeadingpubmed-meshheading:19819121...lld:pubmed
pubmed-article:19819121pubmed:meshHeadingpubmed-meshheading:19819121...lld:pubmed
pubmed-article:19819121pubmed:meshHeadingpubmed-meshheading:19819121...lld:pubmed
pubmed-article:19819121pubmed:meshHeadingpubmed-meshheading:19819121...lld:pubmed
pubmed-article:19819121pubmed:meshHeadingpubmed-meshheading:19819121...lld:pubmed
pubmed-article:19819121pubmed:year2009lld:pubmed
pubmed-article:19819121pubmed:articleTitleThe association between intensive glycemic control and vascular complications in type 2 diabetes mellitus: a meta-analysis.lld:pubmed
pubmed-article:19819121pubmed:affiliationDepartment of Cardiology, Shanghai 6th People's Hospital, Shanghai Jiao tong University School of Medicine, 600 Yishan Road, Shanghai 200233, PR China.lld:pubmed
pubmed-article:19819121pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19819121pubmed:publicationTypeMeta-Analysislld:pubmed